Conditional expression and signaling of a specifically designed Gi-coupled receptor in transgenic mice
暂无分享,去创建一个
B. Conklin | H. Bujard | C. Redfern | P. Coward | M. Y. Degtyarev | Elena K. Lee | A. Kwa | L. Hennighausen | G. Fishman | Elena K. Lee | E. Lee | E. Lee | Elena K. Lee
[1] C. Homcy,et al. G Proteins in the Heart: A Redundant and Diverse Transmembrane Signaling Network , 1991, Circulation.
[2] M. Gossen,et al. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[3] L. Weinstein,et al. Receptor-effector coupling by G proteins: implications for normal and abnormal signal transduction. , 1992, Endocrine reviews.
[4] P. Sótonyi,et al. Increase in functional activity rather than in amount of Gi-alpha in failing human heart with dilated cardiomyopathy. , 1992, Cardiovascular research.
[5] R. Lefkowitz,et al. Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. , 1994, Science.
[6] Y Wang,et al. A regulatory system for use in gene transfer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[7] M. Steinfath,et al. Radioimmunochemical quantification of Gi alpha in right and left ventricles from patients with ischaemic and dilated cardiomyopathy and predominant left ventricular failure. , 1994, Journal of molecular and cellular cardiology.
[8] J. Benovic,et al. Regulation of G protein-coupled receptors by receptor kinases and arrestins. , 1995, Vitamins and hormones.
[9] R. Lefkowitz,et al. Desensitization of G protein-coupled receptors. , 1996, Recent progress in hormone research.
[10] R. Evans,et al. Ecdysone-inducible gene expression in mammalian cells and transgenic mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[11] M. Böhm,et al. Heterotrimeric G proteins in heart disease. , 1996, Cellular signalling.
[12] D. M. Spencer. Creating conditional mutations in mammals. , 1996, Trends in genetics : TIG.
[13] G. Fishman,et al. Conditional transgene expression in the heart. , 1996, Circulation research.
[14] G. Newton,et al. Muscarinic receptor modulation of basal and beta-adrenergic stimulated function of the failing human left ventricle. , 1996, The Journal of clinical investigation.
[15] M. Gossen,et al. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[16] S. Schreiber,et al. Dimeric ligands define a role for transcriptional activation domains in reinitiation , 1996, Nature.
[17] M. Farrar,et al. Activation of the Raf-1 kinase cascade by coumermycin-induced dimerization , 1996, Nature.
[18] L. Hennighausen,et al. Time-Sensitive Reversal of Hyperplasia in Transgenic Mice Expressing SV40 T Antigen , 1996, Science.
[19] Agonist-induced phosphorylation of the kappa-opioid receptor. , 1997, Journal of neurochemistry.
[20] H. Akil,et al. Controlling signaling with a specifically designed Gi-coupled receptor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[21] R Kuhn,et al. Temporally and spatially regulated somatic mutagenesis in mice. , 1998, Nucleic acids research.
[22] B. Roques,et al. Disruption of the κ‐opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective κ‐agonist U‐50,488H and attenuates morphine withdrawal , 1998, The EMBO journal.